The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors
N Liu, H Xu, Q Sun, X Yu, W Chen… - Oxidative Medicine …, 2021 - Wiley Online Library
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
N Liu, H Xu, Q Sun, X Yu, W Chen, H Wei… - Oxidative Medicine and …, 2021 - cir.nii.ac.jp
抄録< jats: p> Uric acid is the end product of purine metabolism in humans. Hyperuricemia is
a metabolic disease caused by the increased formation or reduced excretion of serum uric …
a metabolic disease caused by the increased formation or reduced excretion of serum uric …
The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
N Liu, H Xu, Q Sun, X Yu, W Chen… - Oxidative medicine …, 2021 - pubmed.ncbi.nlm.nih.gov
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
[HTML][HTML] The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
N Liu, H Xu, Q Sun, X Yu, W Chen, H Wei… - … Medicine and Cellular …, 2021 - ncbi.nlm.nih.gov
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
[PDF][PDF] The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
N Liu, H Xu, Q Sun, X Yu, W Chen, H Wei, J Jiang, Y Xu… - 2021 - pdfs.semanticscholar.org
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
N Liu, X Hu, Q Sun, X Yu, W Chen… - Oxidative Medicine …, 2021 - search.proquest.com
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors.
N Liu, H Xu, Q Sun, X Yu, W Chen, H Wei… - … Medicine and Cellular …, 2021 - europepmc.org
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
[PDF][PDF] The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
N Liu, H Xu, Q Sun, X Yu, W Chen, H Wei, J Jiang, Y Xu… - 2021 - scienceopen.com
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …